Injective INJ
Current Price
$4.23 -6.38%
$0.3100 Daily Range (7.33%)
$4.25$4.56
$33.57M Daily Volume
389 BTC
Vol/MktCap: 7.93%
Market Performance
0.11% Relative BTC Volume
The total volume of Injective is $33.57M over the past 24 hours, compared to $30.98B total Bitcoin volume.
Hourly Moving Average
8 SMA $4.44 -4.83%
13 SMA $4.46 -5.13%
21 SMA $4.49 -5.69%
55 SMA $4.54 -6.79%
144 SMA $4.61 -8.19%
Price Performance
-2.77% 1 Hour Change
$4.23 from $4.35
-18.39% 7 Day Change
-$0.7778 from $5.01
-19.51% 14 Day Change
-$0.8253 from $5.06
-8.46% 30 Day Change
-$0.3578 from $4.59
All Time High
March 14, 2024
$52.62 -91.88%
-$48.35 vs. now
24H Change
-28.30M USD -6.27%
-328 BTC
Volume and Supply
Total Supply: 100.00M INJ 
100.00M INJ Available100.00% circulating A lower circulating supply may increase over time, reducing scarcity and potentially causing a drop in price. A higher circulating supply is less susceptible to dilution, offering the potential for a more stable price long-term.
Relative Supply Ratio
5.00 x BTC Supply5:1 supply ratio
RSR reflects potential differences in tokenomics, such as inflation rates, utility, or burn mechanisms, which can impact long-term value and scarcity.
Relative Trade Volume
7.62M INJ
traded over past 24 hours
7.62% of circulating supply
A higher trade volume relative to market cap indicates strong market activity and liquidity, while a lower ratio may suggest reduced interest, lower liquidity, or potential price stagnation.
Conversion Tool
Injective AI Market Analysis
Injective (INJ) is currently trading at $4.35, reflecting a 24-hour decline of 4.42%. The daily price range has been relatively tight, oscillating between a low of $4.33 and a high of $4.56, which indicates limited volatility.
Trading volume stands at approximately 32 million, translating to a volume/market cap ratio of 7.36%. This suggests moderate trading activity, but the negative price trend may be limiting investor interest and participation.
Short-term moving averages are bearish, with the 8 SMA at $4.44 showing a decline of 2.13%. The 55 SMA at $4.54 is down 4.14%, indicating that downward momentum is persisting across multiple timeframes.
The 1-hour RSI is at 23, indicating that INJ is currently in oversold territory, suggesting potential for a short-term rebound. However, the 7-day RSI is at 45, which does not signal strong bullish momentum and reflects a lack of buying pressure over the week.
From a longer-term perspective, INJ has seen a significant decline with a 7-day price change of -16.17% and a 14-day price change of -17.55%. This trend highlights ongoing selling pressure, contributing to investor caution.
The all-time high of $52.62 reached on March 14, 2024, underscores the current price's steep discount, but current market conditions do not support a bullish turnaround in the near term. The overall sentiment remains negative, with several indicators suggesting continued downward pressure.
In conclusion, based on the current data and technical indicators, the recommendation for Injective (INJ) is to Hold. The oversold condition presents potential for a short-term bounce, but the overarching trend remains bearish, warranting caution before committing additional capital.
Trading volume stands at approximately 32 million, translating to a volume/market cap ratio of 7.36%. This suggests moderate trading activity, but the negative price trend may be limiting investor interest and participation.
Short-term moving averages are bearish, with the 8 SMA at $4.44 showing a decline of 2.13%. The 55 SMA at $4.54 is down 4.14%, indicating that downward momentum is persisting across multiple timeframes.
The 1-hour RSI is at 23, indicating that INJ is currently in oversold territory, suggesting potential for a short-term rebound. However, the 7-day RSI is at 45, which does not signal strong bullish momentum and reflects a lack of buying pressure over the week.
From a longer-term perspective, INJ has seen a significant decline with a 7-day price change of -16.17% and a 14-day price change of -17.55%. This trend highlights ongoing selling pressure, contributing to investor caution.
The all-time high of $52.62 reached on March 14, 2024, underscores the current price's steep discount, but current market conditions do not support a bullish turnaround in the near term. The overall sentiment remains negative, with several indicators suggesting continued downward pressure.
In conclusion, based on the current data and technical indicators, the recommendation for Injective (INJ) is to Hold. The oversold condition presents potential for a short-term bounce, but the overarching trend remains bearish, warranting caution before committing additional capital.
Updated 89 minutes ago.
Injective Relative Price at Market Cap of:
Injective TradingView Chart
In The News

How SharpLink Aims to Be the Most 'Focused, Disciplined' Ethereum Treasury in 2026
Ethereum treasury firm SharpLink Gaming hopes to stand apart from the pack by focusing on the long-term—with shareholders top of mind.

Litecoin targets $100: Could ARK Invest’s S-1 filing be LTC’s ‘SUI moment’?
Index-based ETF exposure put Litecoin back on institutional radars, though follow-through remained uncertain.

Trump hits JPMorgan, Capital One, Bank of America, Goldman Sachs
Trump has sued JPMorgan Chase and its CEO Jamie Dimon for $5 billion, accusing them of shutting down his personal and business accounts because of his political views.

Trump Flip‑Flops on Canada’s China Trade Deal, Threatens 100% Tariffs if It Passes
Using Truth Social, President Donald Trump warned Canada that if it became a “drop‑off port” for Chinese goods entering the United States, he would impose 100 % tariffs on…